Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study

Dermatology and Therapy

Volumn 10, Issue 3, 2020, Pages 483-493

  Rinaldi, Fabio ^a   Trink, Anna ^a   Pinto, Daniela ^a  

^a GIULIANI S P A   (Italy)

Author keywords

Alopecia areata; Bee bread; Biomimetic peptides; Microbiota; Plantaricin A; Platelet rich plasma; Postbiotics

Indexed keywords

COSMETIC; GEL; GROWTH FACTOR; PEPTIDE; POSTBIOTIC; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ALOPECIA AREATA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAIR GROWTH; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; MICROBIAL COMMUNITY; MICROFLORA; MIDDLE AGED; PATIENT COMPLIANCE; PLATELET-RICH PLASMA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEVERITY OF ALOPECIA TOOL SCORE; TREATMENT DURATION;

EID: 85083788191     PISSN: 21938210     EISSN: 21909172     Source Type: Journal    
DOI: 10.1007/s13555-020-00369-9     Document Type: Article

References (71)

1. Odom RB, Davidsohn IJ, William D, Henry JB, Berger TG. Clinical diagnosis by laboratory methods. In: Elston, Dirk M, editors. Andrews’ diseases of the skin: clinical dermatology. Philadelphia/Amsterdam: Saunders/Elsevier; 2006, p. 637.
2. Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichol. 2018;10(2):51–60.
3. Dainichi T, Kabashima K. Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J Dermatol Sci. 2017;86(1):3–12
4. Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011. 10.1038/nrdp.2017.11.
5. Paus R, Bertolini M. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. J Investig Dermatol Symp Proc. 2013;16(1):S25–7.
6. Azzawi S, Penzi LR, Senna MM. Immune privilege collapse and alopecia development: is stress a factor. Skin Appendage Disord. 2018;4(4):236–44.
7. Gupta AK, Carviel J, Abramovits W. Treating alopecia areata: current practices versus new directions. Am J Clin Dermatol. 2017;18(1):67–75.
8. Harries MJ, Sun J, Paus R, King LE Jr. Management of alopecia areata. BMJ. 2010;341:c3671.
9. Nardi AE. Psychological impact of alopecia: alopecia may lead to social anxiety. BMJ. 2005;331(7524):1084.
10. Darwin E, Arora H, Hirt PA, Wikramanayake TC, Jimenez JJ. A review of monochromatic light devices for the treatment of alopecia areata. Lasers Med Sci. 2018;33(2):435–44.
11. Damsky W, King BA. JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol. 2017;76(4):736–44.
12. Garg S, Manchanda S. Platelet-rich plasma-an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4:64.
13. Giordano S, Romeo M, di Summa P, et al. A meta-analysis on the evidence of platelet-rich plasma for androgenetic alopecia. Int J Trichology. 2018;10:1–10.
14. Sorbellini E, Trink A, Rinaldi F. Experimental clinical assessment of the use of platelet-rich plasma in dermatology and rationale for its use in the treatment of non-scarring alopecia. Presented at the 35th La Medicina Estetica 4 October 2011. 43.
15. Trink A, Sorbellini E, Bezzola P, et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013;169:690–4.
16. Rinaldi F, Marzani B, Pinto D, Sorbellini E. Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. J Dermatol Treat. 2019;30(6):588–93.
17. Rinaldi F, Marzani B, Pinto D, Sorbellini E. Efficacy of a cosmetic product mimicking PRP in androgenetic alopecia. J Transl Sci. 2019;5:1–5.
18. Pinto D, Sorbellini E, Marzani B, Rucco M, Giuliani G, Rinaldi F. Scalp bacterial shift in Alopecia areata. PLoS ONE. 2019;14(4):e0215206.
19. Ho BS, Ho EXP, Chu CW, et al. Microbiome in the hair follicle of androgenetic alopecia patients. PLoS ONE. 2019;14(5):e0216330.
20. Migacz-Gruszka K, Branicki W, Obtulowicz A, Pirowska M, Gruszka K, Wojas-Pelc A. What’s new in the pathophysiology of alopecia areata? The possible contribution of skin and gut microbiome in the pathogenesis of alopecia–Big opportunities, big challenges, and novel perspectives. Int J Trichol. 2019;11:185–8.
21. Rinaldi F, Pinto D, Giuliani G. Postbiotic evolution in dermatology. EC Microbiology. 2020;16(3):01–4.
22. Finner AM. Alopecia areata: clinical presentation, diagnosis, and unusual cases. Dermatol Ther. 2011;24(3):348–54.
23. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006;55:799–806.
24. Inui S, Nakajima T, Nakagawa K, Itami S. Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases. Int J Dermatol. 2008;47:688–93.
25. Olsen E, Hordinsky M, McDonald-Hull S, et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol. 1999;40:242–6.
26. Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79:613–25. 10.4103/0378-6323.116730.
27. Errichetti E, Figini M, Croatto M, Stinco G. Therapeutic management of classic lichen planopilaris: a systematic review. Clin Cosmet Investig Dermatol. 2018;11:91–102.
28. Sohrab K, Tahir K, Anam E, Tahir JA. Role of autologous platelet-rich plasma (PRP) in limited alopecia areata in local population. J Pak Assoc Dermatol. 2016;26(2):107–11.
29. Borhan R, Gasnier C, Reygagne P. Autologous platelet rich plasma as a treatment of male androgenetic alopecia: study of 14 cases. J Clin Exp Dermatol Res. 2015;6:292.
30. Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet rich plasma: a short overview of certain bioactive components. Open Med (Wars). 2016;11(1):242–7.
31. Gentile P, Garcovich S, Bielli A, et al. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med. 2015;4:1317–23.
32. Pai VV, Bhandari P, Shukla P. Topical peptides as cosmeceuticals. Indian J Dermatol Venereol Leprol. 2017;83:9–18.
33. B€ohlen P, Esch F, Baird A, et al. Acidic fibroblast growth factor (FGF) from bovine brain: amino-terminal sequence and comparison with basic FGF. Embo J. 1985;4:1951–6.
34. Kawano M, Komi-Kuramochi A, Asada M, et al. Comprehensive analysis of FGF and FGFR expression in the skin: fGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. J Invest Dermatol. 2005;124:877–85.
35. Kimura-Ueki M, Oda Y, Oki J, et al. Hair cycle resting phase is regulated by cyclic epithelial FGF18 signaling. J Invest Dermatol. 2012;132:1338–45.
36. Giordano S, Romeo M, di Summa P, et al. A meta-analysis on evidence of platelet-rich plasma for androgenetic alopecia. Int J Trichol. 2018;10:1–10.
37. Gazitaeva ZI, Drobintseva AO, Chung Y, Polyakova VO, Kvetnoy IM. Cosmeceutical product consisting of biomimetic peptides: antiaging effects in vivo and in vitro. Clin Cosmet Investig Dermatol. 2017;10:11–6.
38. Lima TN, Pedriali Moraes CA. Bioactive peptides: applications and relevance for cosmeceuticals. Cosmetics. 2018;5:21.
39. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30:834–9.
40. Lee WJ, Sim HB, Jang YH, et al. Efficacy of a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide on hair growth. Ann Dermatol. 2016;28:438–43.
41. Philp D, Nguyen M, Scheremeta B, et al. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. Faseb J. 2004;18:385–7.
42. Philp D, St-Surin S, Cha HJ, et al. Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci. 2007;1112:95–103.
43. Ito C, Saitoh Y, Fujita Y, et al. Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5. J Cell Physiol. 2003;197:272–83.
44. Bassino E, Zanardi A, Gasparri F, et al. Effects of the biomimetic peptide Sh-Polypeptide 9 (CG-VEGF) on cocultures of human hair follicle dermal papilla cells and microvascular endothelial cells. Exp Dermatol. 2016;25:237–9.
45. Pickart L, Downey D, Lovejoy S, et al. Gly-l-his-l-lys:copper(II)—a human plasma factor with superoxide dismutase-like and wound-healing properties. In: Rotilio G, editor. Superoxide and superoxide dismutase. Amsterdam: Elsevier; 1986. p. 555–8.
46. Uno H, Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol. 1993;101:143S–7S.
47. Chen P, Cescon M, Bonaldo P. Lack of collagen VI promotes wound-induced hair growth. J Invest Dermatol. 2015;135:2358–67.
48. Miller DM, DeSilva D, Pickart L, et al. Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Adv Exp Med Biol. 1990;264:79–84.
49. Vinci C, Caltabiano V, Santoro AM, et al. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets. Diabetologia. 1995;38:39–45.
50. McCormack MC, Nowak KC, Koch RJ. The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. Arch Facial Plast Surg. 2001;3:28–32.
51. Simeon A, Monier F, Emonard H, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-l-lysine- Cu2þ. J Invest Dermatol. 1999;12:957–64.
52. Simeon A, Wegrowski Y, Bontemps Y, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl- l-lysine-Cu(2þ). J Invest Dermatol. 2000;115:962–8.
53. Simeon A, Emonard H, Hornebeck W, et al. The tripeptidecopper complex glycyl-L-histidyl-l-lysine-Cu2þ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;18:2257–665.
54. Raju KS, Alessandri G, Gullino PM. Characterization of a chemoattractant for endothelium induced by angiogenesis effectors. Cancer Res. 1984;44:1579–84.
55. Pickart L. New metal peptide complexes and derivatives used for stimulating growth of hair in warm-blooded animals, especially humans. US Patent 5,120,831. Alexandria: United States Patent and Trademark Office.
56. Compositions for stimulating hair growth containing cupric complexes of peptide derivatives including glycyl-l-histidyl-l-lysine n-octyl ester. US Patent 5,177,061.
57. New glycyl-histidyl-lysyl copper compounds used in stimulating hair growth; US Patent 5,214,032.
58. Metal–peptide compositions and methods for stimulating hair growth, US Patent 5,550,183.
59. Matsumura H, Mohri Y, Binh NT, et al. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016. 10.1126/science.aad4395.
60. Lin WH, Xiang LJ, Shi HX, et al. Fibroblast growth factors stimulate hair growth through b-catenin and Shh expression in C57BL/6 mice. Biomed Res Int. 2015;2015:730139.
61. Yoon SY, Kim K-T, Jo SJ, et al. Induction of hair growth by insulin-like growth factor-1 in 1,763 mhz radiofrequency-irradiated hair follicle cells. PLoS ONE. 2011;6:e28474.
62. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524–33.
63. Toalaa JE, Garcia Varelab R, Garciac HS, Harod V. Postbiotics: an evolving term within the functional foods field. Trends Food Sci Technol. 2018;75:105–14.
64. Tsilingiri K, Rescigno M. Postbiotics: what else? Beneficial Microb. 2013;4(1):101–7.
65. Shenderov BA. Metabiotics: novel idea or natural development of probiotic conception. Microbial Ecol Health Dis. 2013;24:1–8.
66. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G. Probiotic and postbiotic activity in health and disease: comparison on a novel polarized ex vivo organ culture model. Gut. 2012;61:1007–15.
67. Pinto D, Marzani B, Minervini F, et al. Plantaricin A synthesized by Lactobacillus plantarum induces in vitro proliferation and migration of human keratinocytes and increases the expression of TGF-β1, FGF7, VEGF-A and IL-8 genes. Peptides. 2011;32(9):1815–24.
68. Marzani B, Pinto D, Minervini F, et al. The antimicrobial peptide pheromone Plantaricin A increases antioxidant defenses of human keratinocytes and modulates the expression of filaggrin, involucrin, β-defensin 2 and tumor necrosis factor-α genes. Exp Dermatol. 2012;21(9):665–71. 10.1111/j.1600-0625.2012.01538.x.
69. Di Cagno R, Filannino P, Cantatore V, Gobbetti M. Novel solid-state fermentation of bee-collected pollen emulating the natural fermentation process of bee bread. Food Microbiol. 2019;82:218–30.
70. Giuliani G, Gobbetti M, Di Cagno R, Filannino P, Cantatore V, Mascolo A, Marzani B. WO2020016770 (A1) - Microbiological process for the production of bee bread. 2020.
71. SILAB. Oxygenskin®, Reactivates the skin’s oxygenation mechanisms. Saint-Viance: SILAB. https://www.silab.fr/produit-75-oxygeskin_usa.html